Cancer Communications
indexed by SCI
BMC

Is nasopharyngeal cancer really a “Cantonese cancer”?
Joseph Tien Seng Wee , Tam Cam Ha , Susan Li Er Loong , Chao-Nan Qian
Division of Clinical Trials & Epidemiological Sciences, National Cancer Centre, Singapore 169610, Singapore. trdwts@nccs.com.sg
[Abstract] Nasopharyngeal cancer (NPC) is endemic in Southern China, with Guandong province and Hong Kong reporting some of the highest incidences in the world. The journal Science has called it a “Cantonese cancer”. We propose that in fact NPC is a cancer that originated in the BaiYue (“protoTaiKadai” or “protoAustronesian” or “protoZhuang”) peoples and was transmitted to the Han Chinese in southern China through intermarriage. However, the work by John Ho raised the profile of NPC, and because of the high incidence of NPC in Hong Kong and Guangzhou, NPC became known as a Cantonese cancer. We searched historical articles, articles cited in PubMed, Google, monographs, books and Internet articles relating to genetics of the peoples with high populations of NPC. The migration history of these various peoples was extensively researched, and where possible, their genetic fingerprint identified to corroborate with historical accounts. Genetic and anthropological evidence suggest there are a lot of similarities between the BaiYue and the aboriginal peoples of Borneo and Northeast India; between Inuit of Greenland, Austronesian MayaloPolynesians of Southeast Asia and Polynesians of Oceania, suggesting some common ancestry. Genetic studies also suggest the present Cantonese, Minnans and Hakkas are probably an admixture of northern Han and southern BaiYue. All these populations have a high incidence of NPC. Very early contact between southern Chinese and peoples of East Africa and Arabia can also account for the intermediate incidence of NPC in these regions.
Chinese Journal of Cancer 2010, Volume: 29, Issue 5, Page: 517-526
[ PDF Full-text ]
[Google Scholar]


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China